First Manhattan Co
- SEC CIK
- 0000728083
- Latest filing
- Aug 14, 2026
ALDX holding history
Aldeyra Therapeutics, Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 20
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −34,745−100.0% | Sold out | Holders |
| Q1 2026 | 34,745 | $58.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 34,745 | $180.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 34,745 | $181.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 34,745 | $133.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 34,745 | $199.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 34,745 | $173.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 34,745 | $187.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 34,745 | $115.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 34,745 | $113.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 34,745 | $122.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 34,745 | $232.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 34,745 | $291.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 34,745 | $345.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 34,745 | $241.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 34,745 | $185.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 34,745 | $138.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 34,745 | $154.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 34,745 | $138.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 34,745 | $305.0K | <0.1% | −1,001−2.8% | Reduced | Holders |
| Q2 2021 | 35,746 | $405.0K | <0.1% | +35,746 | New | Holders |